Sanofi (SNY) News Today $48.23 -0.50 (-1.03%) (As of 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sanofi (NASDAQ:SNY) Sees Significant Decline in Short InterestDecember 30 at 3:45 PM | americanbankingnews.comShort Interest in Sanofi (NASDAQ:SNY) Drops By 17.4%Sanofi (NASDAQ:SNY - Get Free Report) saw a large decline in short interest in December. As of December 15th, there was short interest totalling 3,740,000 shares, a decline of 17.4% from the November 30th total of 4,530,000 shares. Based on an average daily volume of 2,210,000 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.2% of the shares of the company are short sold.December 29 at 7:48 PM | marketbeat.comTop Research Reports for ServiceNow, AMD & SanofiDecember 23, 2024 | msn.comFulcrum Therapeutics Faces Genzyme Agreement TerminationDecember 23, 2024 | tipranks.comSanofi Appoints Jean-Paul Kress to Board of DirectorsDecember 23, 2024 | tipranks.comPress Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccinesDecember 23, 2024 | globenewswire.comCytokinetics stock rises on Sanofi's rights acquisitionDecember 20, 2024 | in.investing.comSanofi To Buy Rights To Develop Cytokinetics' Aficamten In Greater China From CorxelDecember 20, 2024 | markets.businessinsider.comSanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMSDecember 20, 2024 | markets.businessinsider.comSanofi to acquire rights to develop, commercialize aficamten from CorxelDecember 20, 2024 | markets.businessinsider.comCytokinetics Inc (CYTK) Announces Sanofi's Acquisition of Aficamten Rights in Greater ChinaDecember 20, 2024 | gurufocus.comPresse release: Jean-Paul Kress to join Sanofi's Board of DirectorsDecember 19, 2024 | globenewswire.comSanofi (NASDAQ:SNY) Shares Gap Down - Should You Sell?Sanofi (NASDAQ:SNY) Shares Gap Down - What's Next?December 18, 2024 | marketbeat.comTeva, Sanofi Say Inflammatory Bowel Disease Drug Study Meets Primary EndpointsDecember 17, 2024 | msn.comTeva and Sanofi jump on experimental bowel disease drug successDecember 17, 2024 | finance.yahoo.comTeva and Sanofi (SNY) Jump amid Impressive Drug ResultsDecember 17, 2024 | tipranks.comPositive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn'sDecember 17, 2024 | investopedia.comSanofi (NASDAQ:SNY) Shares Gap Up - Should You Buy?Sanofi (NASDAQ:SNY) Shares Gap Up - Still a Buy?December 17, 2024 | marketbeat.comTrump says is he ‘big believer’ in polio vaccine, AP reportsDecember 17, 2024 | markets.businessinsider.comTeva, Sanofi announce results from Phase 2b RELIEVE UCCD studyDecember 17, 2024 | markets.businessinsider.comTeva, Sanofi report RELIEVE UCCD Phase 2b study met primary endpointsDecember 17, 2024 | markets.businessinsider.comSanofi's 340B Credit Proposal Draws Federal Warning For Statutory ViolationDecember 17, 2024 | benzinga.comWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?December 17, 2024 | benzinga.comWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?December 17, 2024 | benzinga.comBrightInsight Expands Global Digital Partnership with Sanofi to Build Drug Companion Apps for its Major Specialty TherapiesDecember 17, 2024 | globenewswire.comTeva, Sanofi say drug to treat IBD met primary targetsDecember 17, 2024 | reuters.comPress Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's diseaseDecember 17, 2024 | globenewswire.comFranklin Resources Inc. Acquires 395,744 Shares of Sanofi (NASDAQ:SNY)Franklin Resources Inc. boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 13.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,407,452 shares of the company's stock after acquiring an aDecember 15, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by World Investment Advisors LLCWorld Investment Advisors LLC lifted its position in Sanofi (NASDAQ:SNY - Free Report) by 1,020.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,430 shares of the company's stock after purchasing an addiDecember 14, 2024 | marketbeat.comBarclays PLC Increases Stake in Sanofi (NASDAQ:SNY)Barclays PLC boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 107.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 639,772 shares of the company's stock after acquiring an additional 331,445 shares during the period. Barclays PLC's holdinDecember 14, 2024 | marketbeat.comNovavax advances growth strategy through partnership with SanofiDecember 13, 2024 | markets.businessinsider.comSanofi Updates Financials Amid Opella Stake TransferDecember 13, 2024 | tipranks.comSanofi's Tolebrutinib Gets FDA Breakthrough Therapy Designation For NrSPMSDecember 13, 2024 | markets.businessinsider.comPress Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDecember 13, 2024 | globenewswire.comGilead appoints Sanofi official Dietmar Berger as next chief medical officerDecember 12, 2024 | reuters.comShort Interest in Sanofi (NASDAQ:SNY) Declines By 48.7%Sanofi (NASDAQ:SNY - Get Free Report) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 4,530,000 shares, a decrease of 48.7% from the November 15th total of 8,830,000 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 2,020,000 shares, the days-to-cover ratio is presently 2.2 days.December 12, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Downgraded by StockNews.com to HoldStockNews.com downgraded shares of Sanofi from a "buy" rating to a "hold" rating in a research note on Thursday.December 12, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Holdings Trimmed by MML Investors Services LLCMML Investors Services LLC trimmed its stake in Sanofi (NASDAQ:SNY - Free Report) by 7.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 230,536 shares of the company's stock after selling 17,716 shaDecember 11, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $8.04 Million Stock Position in Sanofi (NASDAQ:SNY)Charles Schwab Investment Management Inc. increased its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 31.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 139,505 shares of the company's stock after buying an addiDecember 11, 2024 | marketbeat.comPress Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the USDecember 11, 2024 | globenewswire.comSanofi (NASDAQ:SNY) Shares Sold by Foyston Gordon & Payne IncFoyston Gordon & Payne Inc trimmed its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 80.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,784 shares of the company's stock after selling 24,228 shares during the qDecember 10, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by National Bank of Canada FINational Bank of Canada FI cut its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 16.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 297,845 shares of the company's stock after selling 60,595 shares during the quarDecember 10, 2024 | marketbeat.comSanofi says Sarclisa combos showed benefits in multiple myeloma patientsDecember 9, 2024 | tipranks.comPress Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patientsDecember 9, 2024 | globenewswire.comKovitz Investment Group Partners LLC Sells 16,658 Shares of Sanofi (NASDAQ:SNY)Kovitz Investment Group Partners LLC lowered its stake in Sanofi (NASDAQ:SNY - Free Report) by 21.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,544 shares of the company's stock after selling 16,658 shares during the period. Kovitz InvestmDecember 9, 2024 | marketbeat.comPoint72 Asset Management L.P. Decreases Holdings in Sanofi (NASDAQ:SNY)Point72 Asset Management L.P. cut its stake in Sanofi (NASDAQ:SNY - Free Report) by 58.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,879 shares of the company's stock after selling 122,609 shares during tDecember 9, 2024 | marketbeat.comWellington Management Group LLP Decreases Holdings in Sanofi (NASDAQ:SNY)Wellington Management Group LLP cut its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 2.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,650,334 shares of the company's stock after selling 132,206 shares during thDecember 8, 2024 | marketbeat.comStifel Financial Corp Acquires 10,892 Shares of Sanofi (NASDAQ:SNY)Stifel Financial Corp grew its stake in Sanofi (NASDAQ:SNY - Free Report) by 2.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 562,547 shares of the company's stock after acquiring an additional 10,8December 8, 2024 | marketbeat.comPress Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITPDecember 7, 2024 | globenewswire.comSanofi (NASDAQ:SNY) Shares Bought by Quantinno Capital Management LPQuantinno Capital Management LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 15.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,876 shares of the company's stock after acquiring aDecember 7, 2024 | marketbeat.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Last time you’ll see this priced at $1.00 (Ad)When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore! Click here to review Tim’s special Holiday offer before it’s too late. SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.710.59▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼412▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News NVS News GSK News TAK News BNTX News TEVA News BGNE News MRNA News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
